Pediatric Open-Label Extension Study of Etanercept in Patients With Plaque Psoriasis

Clinical trial NCT00141921 · COMPLETED

Trial details

NCT number: NCT00141921
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pediatric Plaque Psoriasis

Start date: 2005-08-11
Primary completion: 2011-12-19
Enrollment: 182

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.